Hasinur Rahaman Khan
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Hasinur Rahaman Khan has a total of 74 co-authors. Here are the top co-authors by number of shared publications:
- Ahmed Hossain
College of Health Sciences, University of Sharjah, Sharjah, United Arab Emirates
7 shared publications - Faisal Ababneh
Department of Mathematics and Statistics, Sultan Qaboos University, Muscat, Oman
5 shared publications J. Ewart H. Shaw
5 shared publications- Mohammad Mazharul Islam
Department of Statistics, College of Science, Sultan Qaboos University, Muscat, Oman
4 shared publications - Tamanna Howlader
University of Dhaka
3 shared publications - Gias Uddin Ahsan
Department of Public Health, North South University , Dhaka, Bangladesh
2 shared publications
Latest Publications
- Open Access
- 8 May 2026
- Published by Wiley in Statistics in Medicine
- Vol. 45 (10-12) , e70579
Joint Frailty Mixture Cure Model for Recurrent Event Data With Dependent Censoring: An MCEM Approach
Advancements in modern medical technology have enabled cures for a fraction of patients while extending survival times for those who are not cured. For non‐cured patients, disease recurrence is influenced by observed covariates and unobserved individual heterogeneity (random effects). In biomedical studies, dependent censoring is frequently encountered, for example, in cancer patients, where right censoring can be caused by death from unrelated diseases or due to an (unobservable) cure status. This study introduces a joint frailty model for recurrent event data with a cure fraction, effectively capturing heterogeneity and inducing dependent censoring. The proposed multivariate joint frailty mixture cure models incorporate covariates and frailties, together with the event incidence time and latent cure status. The model accounts for the probability of a cure after each recurrence using both the complementary log–log and the logistic link function. A likelihood‐based estimation method is developed using the Monte Carlo Expectation‐Maximization (MCEM) algorithm. Through Monte Carlo simulation, we examine the finite sample properties of the MCEM estimators, supplemented by a real‐world application using secondary data on hospital readmissions for colorectal cancer recurrence post‐surgery. Simulation results suggest lifetime and frailty parameter estimates are unbiased and consistent. Compared to models with identical frailty structure, both the complementary log–log and the logistic cure frailty models with dependent frailties demonstrate a better fit with the real data, as evidenced by lower Akaike information criteria values.
- 8 May 2026
- Published by Wiley in Statistics in Medicine
- Vol. 45 (10-12) , e70579
Open AccessJoint Frailty Mixture Cure Model for Recurrent Event Data With Dependent Censoring: An MCEM Approach
Advancements in modern medical technology have enabled cures for a fraction of patients while extending survival times for those who are not cured. For non‐cured patients, disease recurrence is influenced by observed covariates and unobserved individual heterogeneity (random effects). In biomedical studies, dependent censoring is frequently encountered, for example, in cancer patients, where right censoring can be caused by death from unrelated diseases or due to an (unobservable) cure status. This study introduces a joint frailty model for recurrent event data with a cure fraction, effectively capturing heterogeneity and inducing dependent censoring. The proposed multivariate joint frailty mixture cure models incorporate covariates and frailties, together with the event incidence time and latent cure status. The model accounts for the probability of a cure after each recurrence using both the complementary log–log and the logistic link function. A likelihood‐based estimation method is developed using the Monte Carlo Expectation‐Maximization (MCEM) algorithm. Through Monte Carlo simulation, we examine the finite sample properties of the MCEM estimators, supplemented by a real‐world application using secondary data on hospital readmissions for colorectal cancer recurrence post‐surgery. Simulation results suggest lifetime and frailty parameter estimates are unbiased and consistent. Compared to models with identical frailty structure, both the complementary log–log and the logistic cure frailty models with dependent frailties demonstrate a better fit with the real data, as evidenced by lower Akaike information criteria values.
- Open Access
- 31 January 2026
- Published by Springer Nature in BMC Infectious Diseases
- Vol. 26 (1)
Tuberculosis notification trends and treatment outcomes in Bangladesh: findings from a National TB Program data, 2019–2021
Tuberculosis (TB) remains a major public health challenge in Bangladesh, which ranks among the world’s high-burden countries. While previous studies
- 31 January 2026
- Published by Springer Nature in BMC Infectious Diseases
- Vol. 26 (1)
Open AccessTuberculosis notification trends and treatment outcomes in Bangladesh: findings from a National TB Program data, 2019–2021
Tuberculosis (TB) remains a major public health challenge in Bangladesh, which ranks among the world’s high-burden countries. While previous studies
- 21 December 2025
- Published by Taylor & Francis in Journal of Biopharmaceutical Statistics
- Vol. 36 (6) , 1713-1730
Change-point detection in Weibull-accelerated failure time models via narrowest significance pursuit
Survival data are often subject to abrupt structural changes due to unforeseen natural or anthropogenic events, which may significantly alter the hazard function and introduce shifts in model parameters. Traditional survival models typically assume time-invariant hazard structures and are therefore inadequate in capturing such distributional shifts. To address this limitation, we adapt the Narrowest Significance Pursuit (NSP) methodology proposed by Fryzlewicz (2024) for change-point detection within the framework of accelerated failure time (AFT) models. The NSP algorithm employs a multiscale sup-norm loss to fit Weibull AFT models across varying subintervals, recursively identifying the narrowest intervals where linearity is statistically violated at a user-specified global significance level. Change-points are detected as abrupt changes in the underlying parameters of the survival model, and the method does not require prior specification of the number or location of these points. We conduct an extensive simulation study to evaluate the performance of the proposed approach under various change-point scenarios, censoring levels, and compare it with the existing methods in the literature. Additionally, a real-world dataset is analyzed to demonstrate the practical applicability of the method. The empirical results highlight the accuracy and robustness of NSP in detecting structural changes in survival distributions, making it a valuable tool for analyzing heterogeneous survival data in dynamic risk environments.
- 21 December 2025
- Published by Taylor & Francis in Journal of Biopharmaceutical Statistics
- Vol. 36 (6) , 1713-1730
Change-point detection in Weibull-accelerated failure time models via narrowest significance pursuit
Survival data are often subject to abrupt structural changes due to unforeseen natural or anthropogenic events, which may significantly alter the hazard function and introduce shifts in model parameters. Traditional survival models typically assume time-invariant hazard structures and are therefore inadequate in capturing such distributional shifts. To address this limitation, we adapt the Narrowest Significance Pursuit (NSP) methodology proposed by Fryzlewicz (2024) for change-point detection within the framework of accelerated failure time (AFT) models. The NSP algorithm employs a multiscale sup-norm loss to fit Weibull AFT models across varying subintervals, recursively identifying the narrowest intervals where linearity is statistically violated at a user-specified global significance level. Change-points are detected as abrupt changes in the underlying parameters of the survival model, and the method does not require prior specification of the number or location of these points. We conduct an extensive simulation study to evaluate the performance of the proposed approach under various change-point scenarios, censoring levels, and compare it with the existing methods in the literature. Additionally, a real-world dataset is analyzed to demonstrate the practical applicability of the method. The empirical results highlight the accuracy and robustness of NSP in detecting structural changes in survival distributions, making it a valuable tool for analyzing heterogeneous survival data in dynamic risk environments.
- Open Access
- 6 December 2025
- Published by Springer Nature in Discover Social Science and Health
- Vol. 6 (1)
Determinants of inequities in access to healthcare among transgender people in Bangladesh
- 6 December 2025
- Published by Springer Nature in Discover Social Science and Health
- Vol. 6 (1)
Open AccessDeterminants of inequities in access to healthcare among transgender people in Bangladesh
- Open Access
- 9 October 2025
- Published by Springer Nature in BMC Public Health
- Vol. 25 (1) , 1-9
Disparities in contraceptive preferences among Bangladeshi women: a multilevel logistic regression study
Understanding the contraceptive preferences of currently married women who are not using any method but intend to do so in the future is critical for addressing unmet need and informing targeted family planning strategies. In Bangladesh, despite progress in contraceptive uptake, disparities persist across socio-demographic groups and geographic regions. This study examines the determinants of preferred future contraceptive methods among non-using but intending women in Bangladesh using a multilevel analytic framework. We used data from the 2014 Bangladesh Demographic and Health Survey (BDHS), focusing on 3,662 currently married women aged 15–49 who were not using any contraceptive method but intended to adopt one in the future. The outcome variable, preferred future contraceptive method, was categorized into three groups: Pill (reference), Injection, and Other methods (e.g., condom, sterilization, Norplant). A two-level multinomial logistic regression model was applied, with women (level 1) nested within administrative divisions (level 2), using a Bayesian estimation approach. The Pill was the most preferred method overall (49%), followed by Other methods (30%) and Injection (21%). Preference patterns varied by age, education, parity, wealth, and place of residence. Women with higher education had significantly greater odds of preferring other methods over pills (OR = 1.68, 95% CI: 1.14–2.51), while those with more children were more likely to prefer injections. Urban women were more inclined to prefer other methods compared to rural women (OR = 1.38, 95% CI: 1.14–1.71). The analysis revealed significant variation across divisions, highlighting contextual influences on contraceptive preferences. Contraceptive preferences among non-using but intending women in Bangladesh are shaped by a complex interplay of individual and regional factors. Programs aiming to reduce unmet need and method discontinuation should adopt tailored strategies that consider age, education, parity, and regional disparities. Enhancing method choice, promoting female education, and improving service delivery in underserved regions are essential for achieving reproductive health equity and advancing national and global family planning goals.
- 9 October 2025
- Published by Springer Nature in BMC Public Health
- Vol. 25 (1) , 1-9
Open AccessDisparities in contraceptive preferences among Bangladeshi women: a multilevel logistic regression study
Understanding the contraceptive preferences of currently married women who are not using any method but intend to do so in the future is critical for addressing unmet need and informing targeted family planning strategies. In Bangladesh, despite progress in contraceptive uptake, disparities persist across socio-demographic groups and geographic regions. This study examines the determinants of preferred future contraceptive methods among non-using but intending women in Bangladesh using a multilevel analytic framework. We used data from the 2014 Bangladesh Demographic and Health Survey (BDHS), focusing on 3,662 currently married women aged 15–49 who were not using any contraceptive method but intended to adopt one in the future. The outcome variable, preferred future contraceptive method, was categorized into three groups: Pill (reference), Injection, and Other methods (e.g., condom, sterilization, Norplant). A two-level multinomial logistic regression model was applied, with women (level 1) nested within administrative divisions (level 2), using a Bayesian estimation approach. The Pill was the most preferred method overall (49%), followed by Other methods (30%) and Injection (21%). Preference patterns varied by age, education, parity, wealth, and place of residence. Women with higher education had significantly greater odds of preferring other methods over pills (OR = 1.68, 95% CI: 1.14–2.51), while those with more children were more likely to prefer injections. Urban women were more inclined to prefer other methods compared to rural women (OR = 1.38, 95% CI: 1.14–1.71). The analysis revealed significant variation across divisions, highlighting contextual influences on contraceptive preferences. Contraceptive preferences among non-using but intending women in Bangladesh are shaped by a complex interplay of individual and regional factors. Programs aiming to reduce unmet need and method discontinuation should adopt tailored strategies that consider age, education, parity, and regional disparities. Enhancing method choice, promoting female education, and improving service delivery in underserved regions are essential for achieving reproductive health equity and advancing national and global family planning goals.
- 8 April 2025
- Published by Taylor & Francis in Communications in Statistics - Simulation and Computation
- Vol. 55 (8) , 1-18
Variable selection for censored data with greedy algorithm based adaptive quantile regression models
- 8 April 2025
- Published by Taylor & Francis in Communications in Statistics - Simulation and Computation
- Vol. 55 (8) , 1-18
Variable selection for censored data with greedy algorithm based adaptive quantile regression models
- 28 June 2022
- Published by Taylor & Francis in Communications in Statistics - Simulation and Computation
- Vol. 53 (6) , 1-23
Ranking based variable selection for censored data using AFT models
Numerous variable selection techniques have been developed for complete high-dimensional data but very few of them for censored data. The techniques for complete data must be modified if censoring is present. In this paper, we consider the variable selection technique for accelerated failure time (AFT) models by extending the ranking-based variable selection (RBVS) algorithm and its iterative procedure as proposed in the work of Baranowski et al. through the Stute’s weighted least square technique. Simulation studies are conducted to demonstrate the performance of the proposed methods. We further illustrate the performance of this method with a mantle cell lymphoma microarray example. When there is no correlation among the covariates, the proposed method outperforms the iterative sure independence screening and stability selection methods in terms of overall performance for high-dimensional data. Real data analysis also suggests that the proposed method can be chosen for high-dimensional censored data analysis in parallel to other methods in the literature.
- 28 June 2022
- Published by Taylor & Francis in Communications in Statistics - Simulation and Computation
- Vol. 53 (6) , 1-23
Ranking based variable selection for censored data using AFT models
Numerous variable selection techniques have been developed for complete high-dimensional data but very few of them for censored data. The techniques for complete data must be modified if censoring is present. In this paper, we consider the variable selection technique for accelerated failure time (AFT) models by extending the ranking-based variable selection (RBVS) algorithm and its iterative procedure as proposed in the work of Baranowski et al. through the Stute’s weighted least square technique. Simulation studies are conducted to demonstrate the performance of the proposed methods. We further illustrate the performance of this method with a mantle cell lymphoma microarray example. When there is no correlation among the covariates, the proposed method outperforms the iterative sure independence screening and stability selection methods in terms of overall performance for high-dimensional data. Real data analysis also suggests that the proposed method can be chosen for high-dimensional censored data analysis in parallel to other methods in the literature.
- Open Access
Side Effects of COVID-19 Vaccines and Perceptions about COVID-19 and Its Vaccines in Bangladesh
Background One of the primary reasons for hesitancy in taking COVID-19 vaccines is the fear of side effects. This study primarily aims to inspect the potential side effects of the COVID-19 vaccines circulated in Bangladesh. Methods The study was a cross-sectional anonymous online survey conducted across Bangladesh. Data were collected from December 2 to December 26, 2021. The study included consenting (informed) Bangladeshi individuals aged 12 and above who had received at least one dose of the COVID-19 vaccines. Analyses were carried out through exploratory analysis, Chi-square test, and logistic regression. Results A total of 1,180 (males-63.89%, age 50 years or over-65.4%, rural-52.86%) vaccinated people participated in the study. Less than half of the participants (39.48%) reported at least one side effect after receiving their COVID-19 vaccine. Injection-site pain, fever, headache, redness/swelling at the injection site, and lethargy were the most commonly reported adverse effects, all of which were mild and lasted 1-3 days. Side effects were most prevalent (about 80%) among individuals who received Pfizer-BioNTech and Moderna vaccines and were least common among those who received Sinopharm and Sinovac vaccines (21%-28%). When compared to the Sinopharm vaccines, the OxfordAstraZeneca, Pfizer-BioNTech, and Moderna vaccines were 4.51 (95% CI: 2.53-8.04) times, 5.37 (95% CI: 2.57-11.22) times, and 4.28 (95% CI: 2.28-8.05) times likelier to produce side effects. Furthermore, males, those over 50 years old, urban dwellers, smokers, and those with underlying health issues had a considerably increased risk of developing side effects. A lack of confidence in vaccines’ efficacy and a substantial level of hesitancy in allowing children (age five years or over) and older people (70 years or over) to receive COVID-19 vaccines were also observed. Conclusion Side effects of COVID-19 vaccines are minimal, demonstrating their safety. Further studies are required to establish the efficacy of the vaccines.
Open AccessSide Effects of COVID-19 Vaccines and Perceptions about COVID-19 and Its Vaccines in Bangladesh
Background One of the primary reasons for hesitancy in taking COVID-19 vaccines is the fear of side effects. This study primarily aims to inspect the potential side effects of the COVID-19 vaccines circulated in Bangladesh. Methods The study was a cross-sectional anonymous online survey conducted across Bangladesh. Data were collected from December 2 to December 26, 2021. The study included consenting (informed) Bangladeshi individuals aged 12 and above who had received at least one dose of the COVID-19 vaccines. Analyses were carried out through exploratory analysis, Chi-square test, and logistic regression. Results A total of 1,180 (males-63.89%, age 50 years or over-65.4%, rural-52.86%) vaccinated people participated in the study. Less than half of the participants (39.48%) reported at least one side effect after receiving their COVID-19 vaccine. Injection-site pain, fever, headache, redness/swelling at the injection site, and lethargy were the most commonly reported adverse effects, all of which were mild and lasted 1-3 days. Side effects were most prevalent (about 80%) among individuals who received Pfizer-BioNTech and Moderna vaccines and were least common among those who received Sinopharm and Sinovac vaccines (21%-28%). When compared to the Sinopharm vaccines, the OxfordAstraZeneca, Pfizer-BioNTech, and Moderna vaccines were 4.51 (95% CI: 2.53-8.04) times, 5.37 (95% CI: 2.57-11.22) times, and 4.28 (95% CI: 2.28-8.05) times likelier to produce side effects. Furthermore, males, those over 50 years old, urban dwellers, smokers, and those with underlying health issues had a considerably increased risk of developing side effects. A lack of confidence in vaccines’ efficacy and a substantial level of hesitancy in allowing children (age five years or over) and older people (70 years or over) to receive COVID-19 vaccines were also observed. Conclusion Side effects of COVID-19 vaccines are minimal, demonstrating their safety. Further studies are required to establish the efficacy of the vaccines.
- Open Access
- 1 December 2021
- Published by Walter de Gruyter GmbH in Biometrical Letters
- Vol. 58 (2) , 133-147
On sample size calculation in testing treatment efficacy in clinical trials
Summary: Sample size calculation is an integral part of any clinical trial design, and determining the optimal sample size for a study ensures adequate power to detect statistical significance. It is a critical step in designing a planned research protocol, since using too many participants in a study is expensive, exposing more subjects to the procedure. If a study is underpowered, it will be statistically inconclusive and may cause the whole protocol to fail. Amidst the attempt to maximize power and the underlying effort to minimize the budget, the optimization of both has become a significant issue in the determination of sample size for clinical trials in recent decades. Although it is hard to generalize a single method for sample size calculation, this study is an attempt to offer something that might be a basis for finding a permanent answer to the contradictions of sample size determination, by the use of simulation studies under simple random and cluster sampling schemes, with different sizes of power and type I error. The effective sample size is much higher when the design effect of the sampling method is smaller, particularly less than 1. Sample size increases for cluster sampling when the number of clusters increases.
- 1 December 2021
- Published by Walter de Gruyter GmbH in Biometrical Letters
- Vol. 58 (2) , 133-147
Open AccessOn sample size calculation in testing treatment efficacy in clinical trials
Summary: Sample size calculation is an integral part of any clinical trial design, and determining the optimal sample size for a study ensures adequate power to detect statistical significance. It is a critical step in designing a planned research protocol, since using too many participants in a study is expensive, exposing more subjects to the procedure. If a study is underpowered, it will be statistically inconclusive and may cause the whole protocol to fail. Amidst the attempt to maximize power and the underlying effort to minimize the budget, the optimization of both has become a significant issue in the determination of sample size for clinical trials in recent decades. Although it is hard to generalize a single method for sample size calculation, this study is an attempt to offer something that might be a basis for finding a permanent answer to the contradictions of sample size determination, by the use of simulation studies under simple random and cluster sampling schemes, with different sizes of power and type I error. The effective sample size is much higher when the design effect of the sampling method is smaller, particularly less than 1. Sample size increases for cluster sampling when the number of clusters increases.